A detailed history of Beddow Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Beddow Capital Management Inc holds 34,055 shares of BMY stock, worth $1.79 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
34,055
Previous 32,655 4.29%
Holding current value
$1.79 Million
Previous $1.77 Million 20.16%
% of portfolio
0.62%
Previous 0.77%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$40.25 - $52.99 $56,350 - $74,186
1,400 Added 4.29%
34,055 $1.41 Million
Q1 2024

Apr 24, 2024

BUY
$47.98 - $54.4 $179,877 - $203,945
3,749 Added 12.97%
32,655 $1.77 Million
Q4 2023

Jan 25, 2024

SELL
$48.48 - $57.85 $1.37 Million - $1.64 Million
-28,323 Reduced 49.49%
28,906 $1.48 Million
Q3 2023

Nov 07, 2023

SELL
$57.89 - $64.73 $85,735 - $95,865
-1,481 Reduced 2.52%
57,229 $3.32 Million
Q2 2023

Aug 08, 2023

BUY
$63.71 - $70.74 $7,963 - $8,842
125 Added 0.21%
58,710 $3.76 Million
Q1 2023

May 09, 2023

BUY
$65.71 - $74.53 $49,282 - $55,897
750 Added 1.3%
58,585 $4.06 Million
Q4 2022

Feb 02, 2023

SELL
$68.48 - $81.09 $11,984 - $14,190
-175 Reduced 0.3%
57,835 $4.16 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $65 - $38,420
500 Added 0.87%
58,010 $4.12 Million
Q2 2022

Aug 02, 2022

BUY
$72.62 - $79.98 $164,121 - $180,754
2,260 Added 4.09%
57,510 $4.43 Million
Q1 2022

May 04, 2022

BUY
$61.48 - $73.72 $124,497 - $149,283
2,025 Added 3.8%
55,250 $4.04 Million
Q4 2021

Feb 02, 2022

BUY
$53.63 - $62.52 $510,825 - $595,503
9,525 Added 21.8%
53,225 $3.32 Million
Q3 2021

Oct 27, 2021

BUY
$59.17 - $69.31 $2.59 Million - $3.03 Million
43,700 New
43,700 $2.59 Million
Q4 2020

Feb 10, 2021

SELL
$57.74 - $65.43 $1.81 Million - $2.05 Million
-31,345 Closed
0 $0
Q3 2020

Nov 05, 2020

SELL
$57.43 - $63.64 $40,201 - $44,548
-700 Reduced 2.18%
31,345 $1.89 Million
Q2 2020

Aug 05, 2020

SELL
$54.82 - $64.09 $280,952 - $328,461
-5,125 Reduced 13.79%
32,045 $1.88 Million
Q1 2020

May 07, 2020

SELL
$46.4 - $67.43 $125,744 - $182,735
-2,710 Reduced 6.8%
37,170 $2.07 Million
Q4 2019

Feb 05, 2020

BUY
$49.21 - $64.19 $84,149 - $109,764
1,710 Added 4.48%
39,880 $2.56 Million
Q3 2019

Nov 07, 2019

SELL
$42.77 - $50.71 $9,837 - $11,663
-230 Reduced 0.6%
38,170 $1.94 Million
Q2 2019

Aug 09, 2019

SELL
$44.62 - $49.34 $475,649 - $525,964
-10,660 Reduced 21.73%
38,400 $1.74 Million
Q1 2019

May 13, 2019

BUY
$45.12 - $53.8 $1.35 Million - $1.61 Million
30,005 Added 157.47%
49,060 $1.77 Million
Q4 2018

Feb 06, 2019

BUY
$48.76 - $63.23 $929,121 - $1.2 Million
19,055 New
19,055 $360,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $112B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Beddow Capital Management Inc Portfolio

Follow Beddow Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beddow Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Beddow Capital Management Inc with notifications on news.